

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.88272859 |
| 2 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 6.33781217 |
| 3 | B cell receptor signaling pathway (GO:0050853) | 5.80063500 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.74966116 |
| 5 | cellular response to zinc ion (GO:0071294) | 5.66589139 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.60970021 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.60970021 |
| 8 | positive regulation of antigen processing and presentation (GO:0002579) | 5.45686013 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42368565 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.14079571 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 4.83584379 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.80358080 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.80358080 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.71825238 |
| 15 | regulation of B cell differentiation (GO:0045577) | 4.71084620 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.68626459 |
| 17 | regulation of antigen processing and presentation (GO:0002577) | 4.61692886 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.53413288 |
| 19 | negative thymic T cell selection (GO:0045060) | 4.42432255 |
| 20 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.41127757 |
| 21 | positive regulation of type 2 immune response (GO:0002830) | 4.35098742 |
| 22 | detection of bacterium (GO:0016045) | 4.28388499 |
| 23 | detection of other organism (GO:0098543) | 4.22876475 |
| 24 | myeloid dendritic cell differentiation (GO:0043011) | 4.21627966 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.16032181 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 4.15737322 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 4.10707738 |
| 28 | negative T cell selection (GO:0043383) | 4.07959864 |
| 29 | myeloid dendritic cell activation (GO:0001773) | 4.06024945 |
| 30 | mature B cell differentiation (GO:0002335) | 4.01458243 |
| 31 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.95763727 |
| 32 | positive regulation of interleukin-12 production (GO:0032735) | 3.93195678 |
| 33 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.88398219 |
| 34 | regulation of B cell proliferation (GO:0030888) | 3.85269781 |
| 35 | regulation of interferon-alpha production (GO:0032647) | 3.85254058 |
| 36 | neutrophil activation (GO:0042119) | 3.79135782 |
| 37 | positive regulation of macrophage cytokine production (GO:0060907) | 3.76948131 |
| 38 | positive regulation of B cell proliferation (GO:0030890) | 3.72969902 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.72392466 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.71476183 |
| 41 | thymic T cell selection (GO:0045061) | 3.70058163 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.66399496 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.63994533 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.61853765 |
| 45 | B cell mediated immunity (GO:0019724) | 3.61695434 |
| 46 | cellular extravasation (GO:0045123) | 3.60665038 |
| 47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59896887 |
| 48 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.59095937 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57562977 |
| 50 | response to type I interferon (GO:0034340) | 3.55783547 |
| 51 | defense response to protozoan (GO:0042832) | 3.55567648 |
| 52 | B cell proliferation (GO:0042100) | 3.50752121 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.49833357 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.49833357 |
| 55 | positive regulation of B cell activation (GO:0050871) | 3.48924996 |
| 56 | positive regulation of interleukin-2 production (GO:0032743) | 3.47532481 |
| 57 | granulocyte activation (GO:0036230) | 3.47454816 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.46587914 |
| 59 | negative regulation of B cell proliferation (GO:0030889) | 3.46570677 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.44809210 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.44569810 |
| 62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.42294935 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40805864 |
| 64 | germinal center formation (GO:0002467) | 3.39934886 |
| 65 | dendritic cell differentiation (GO:0097028) | 3.39262331 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37639913 |
| 67 | response to host immune response (GO:0052572) | 3.37639913 |
| 68 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.37076270 |
| 69 | cytidine metabolic process (GO:0046087) | 3.36682449 |
| 70 | cytidine catabolic process (GO:0006216) | 3.36682449 |
| 71 | cytidine deamination (GO:0009972) | 3.36682449 |
| 72 | natural killer cell mediated immunity (GO:0002228) | 3.33805980 |
| 73 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.33805980 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.32077638 |
| 75 | regulation of interleukin-12 production (GO:0032655) | 3.31232776 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30685071 |
| 77 | T cell selection (GO:0045058) | 3.29121771 |
| 78 | cellular response to interferon-beta (GO:0035458) | 3.26706594 |
| 79 | T-helper 1 type immune response (GO:0042088) | 3.26332014 |
| 80 | response to muramyl dipeptide (GO:0032495) | 3.26133887 |
| 81 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.25507552 |
| 82 | respiratory burst (GO:0045730) | 3.25416048 |
| 83 | microglial cell activation (GO:0001774) | 3.25279765 |
| 84 | positive T cell selection (GO:0043368) | 3.24926448 |
| 85 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24327034 |
| 86 | regulation of B cell apoptotic process (GO:0002902) | 3.24008733 |
| 87 | positive regulation of granulocyte differentiation (GO:0030854) | 3.24007659 |
| 88 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.22275898 |
| 89 | positive regulation of neutrophil migration (GO:1902624) | 3.22275898 |
| 90 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.21778145 |
| 91 | regulation of B cell activation (GO:0050864) | 3.21318879 |
| 92 | mature B cell differentiation involved in immune response (GO:0002313) | 3.20782102 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 3.20605769 |
| 94 | negative regulation of B cell apoptotic process (GO:0002903) | 3.19257884 |
| 95 | regulation of T cell tolerance induction (GO:0002664) | 3.17944235 |
| 96 | B cell homeostasis (GO:0001782) | 3.15317116 |
| 97 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.14995952 |
| 98 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14176067 |
| 99 | response to host (GO:0075136) | 3.13970616 |
| 100 | response to host defenses (GO:0052200) | 3.13970616 |
| 101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.13970616 |
| 102 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.13334145 |
| 103 | positive regulation of mast cell activation (GO:0033005) | 3.13182833 |
| 104 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.11261271 |
| 105 | cellular response to interleukin-15 (GO:0071350) | 3.10158748 |
| 106 | positive regulation of interferon-beta production (GO:0032728) | 3.10118891 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 3.06148653 |
| 108 | cellular response to ethanol (GO:0071361) | 3.05709864 |
| 109 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04723284 |
| 110 | modulation by symbiont of host defense response (GO:0052031) | 3.04723284 |
| 111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04723284 |
| 112 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04723284 |
| 113 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04723284 |
| 114 | modulation by symbiont of host immune response (GO:0052553) | 3.04723284 |
| 115 | detection of biotic stimulus (GO:0009595) | 3.03075113 |
| 116 | regulation of mast cell activation (GO:0033003) | 3.02882578 |
| 117 | T cell costimulation (GO:0031295) | 3.01143654 |
| 118 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.01140247 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01005367 |
| 120 | response to interleukin-15 (GO:0070672) | 3.00542931 |
| 121 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.99397815 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99282352 |
| 123 | lymphocyte homeostasis (GO:0002260) | 2.98919233 |
| 124 | response to protozoan (GO:0001562) | 2.97779604 |
| 125 | lymphocyte costimulation (GO:0031294) | 2.97176975 |
| 126 | T cell migration (GO:0072678) | 2.96860019 |
| 127 | response to peptidoglycan (GO:0032494) | 2.96526079 |
| 128 | histone H3-K36 demethylation (GO:0070544) | 2.96032982 |
| 129 | detection of molecule of bacterial origin (GO:0032490) | 2.95141461 |
| 130 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.94278237 |
| 131 | dendritic cell chemotaxis (GO:0002407) | 2.93786010 |
| 132 | regulation of granulocyte differentiation (GO:0030852) | 2.91799527 |
| 133 | lymphocyte mediated immunity (GO:0002449) | 2.91688546 |
| 134 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.91675835 |
| 135 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.90838207 |
| 136 | macrophage activation (GO:0042116) | 2.88415713 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88071478 |
| 138 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87335496 |
| 139 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.86835341 |
| 140 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86635969 |
| 141 | regulation of germinal center formation (GO:0002634) | 2.84901035 |
| 142 | activated T cell proliferation (GO:0050798) | 2.83929329 |
| 143 | leukocyte aggregation (GO:0070486) | 2.82615056 |
| 144 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81471918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.85681385 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.99225623 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.51717514 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.86863274 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.30514772 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.23539655 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.06246616 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.55626253 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30228321 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28304516 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23611665 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.16697890 |
| 13 | * MYC_22102868_ChIP-Seq_BL_Human | 2.92407267 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90452070 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89995078 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61160262 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.56915566 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.54536866 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44623686 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31203119 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.29901383 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.26735271 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25857871 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.21443954 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16369869 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15705435 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15427838 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08619272 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.06830028 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.06644767 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.98372199 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95144928 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87434944 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84191354 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78510615 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76049871 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72230578 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68072510 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67372430 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65016423 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57515495 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.54122358 |
| 43 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.53284868 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51440345 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46385507 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46286534 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39808030 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37117937 |
| 49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34578601 |
| 50 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34568370 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34442842 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33960216 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32672684 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31574578 |
| 55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30781125 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28711127 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.26913759 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26849806 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24835978 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24133258 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23695313 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22493553 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22059317 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18386126 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17555870 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16398599 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13990440 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11062393 |
| 69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08173762 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05004987 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04884547 |
| 72 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03874600 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03480122 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01430651 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01160865 |
| 76 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.99155675 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99104787 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97354439 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95601713 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94431776 |
| 81 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93211041 |
| 82 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92945382 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90627285 |
| 84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88629380 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84396179 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83272040 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82959871 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82337639 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81973477 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79136579 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78004940 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76078744 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75639328 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74348749 |
| 95 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73865644 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72269898 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.69373114 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 0.68837468 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68265823 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 0.67182963 |
| 101 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.66987327 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.66701409 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64678594 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62344523 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62062421 |
| 106 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.58452462 |
| 107 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58402531 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58334241 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.57044356 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.56995406 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56693458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 6.35043201 |
| 2 | MP0000685_abnormal_immune_system | 4.52992198 |
| 3 | * MP0005387_immune_system_phenotype | 4.45960379 |
| 4 | * MP0001790_abnormal_immune_system | 4.45960379 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.96537834 |
| 6 | MP0004510_myositis | 3.48835247 |
| 7 | MP0005671_abnormal_response_to | 3.46982526 |
| 8 | MP0003303_peritoneal_inflammation | 3.35963504 |
| 9 | MP0002254_reproductive_system_inflammat | 3.32495635 |
| 10 | * MP0002452_abnormal_antigen_presenting | 3.31609720 |
| 11 | * MP0005000_abnormal_immune_tolerance | 3.21316568 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.95120573 |
| 13 | * MP0002723_abnormal_immune_serum | 2.85762913 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.74579301 |
| 15 | * MP0001819_abnormal_immune_cell | 2.72815641 |
| 16 | MP0009785_altered_susceptibility_to | 2.62601420 |
| 17 | * MP0005025_abnormal_response_to | 2.58674366 |
| 18 | MP0003436_decreased_susceptibility_to | 2.57234366 |
| 19 | * MP0002419_abnormal_innate_immunity | 2.47655722 |
| 20 | MP0005310_abnormal_salivary_gland | 2.47080052 |
| 21 | MP0001853_heart_inflammation | 2.41825186 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.25004225 |
| 23 | * MP0000716_abnormal_immune_system | 2.22325197 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.12319617 |
| 25 | MP0001873_stomach_inflammation | 2.07147975 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.95992283 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.95408126 |
| 28 | MP0002405_respiratory_system_inflammati | 1.90693983 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.83536190 |
| 30 | * MP0002429_abnormal_blood_cell | 1.75049537 |
| 31 | * MP0001845_abnormal_inflammatory_respons | 1.75019174 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.70866097 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.67758552 |
| 34 | MP0002006_tumorigenesis | 1.62745299 |
| 35 | * MP0002722_abnormal_immune_system | 1.62346516 |
| 36 | MP0006082_CNS_inflammation | 1.58931620 |
| 37 | MP0004947_skin_inflammation | 1.58571427 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.58132685 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.55030130 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.54104155 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.51072978 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.51070801 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.43923306 |
| 44 | MP0004381_abnormal_hair_follicle | 1.38943506 |
| 45 | MP0008469_abnormal_protein_level | 1.23643299 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.16595167 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.16110439 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.09850103 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.05976155 |
| 50 | MP0009764_decreased_sensitivity_to | 1.03415280 |
| 51 | MP0003724_increased_susceptibility_to | 1.03170023 |
| 52 | MP0002132_abnormal_respiratory_system | 1.01847859 |
| 53 | MP0003866_abnormal_defecation | 0.99675589 |
| 54 | MP0003448_altered_tumor_morphology | 0.97993212 |
| 55 | MP0002933_joint_inflammation | 0.97855593 |
| 56 | MP0001346_abnormal_lacrimal_gland | 0.97139176 |
| 57 | MP0008057_abnormal_DNA_replication | 0.97090037 |
| 58 | MP0003091_abnormal_cell_migration | 0.96864599 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 0.93380621 |
| 60 | MP0005174_abnormal_tail_pigmentation | 0.93143458 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 0.92618321 |
| 62 | MP0002396_abnormal_hematopoietic_system | 0.91112607 |
| 63 | MP0004883_abnormal_blood_vessel | 0.90735973 |
| 64 | MP0003045_fibrosis | 0.88802668 |
| 65 | MP0005451_abnormal_body_composition | 0.87341862 |
| 66 | MP0002136_abnormal_kidney_physiology | 0.87235091 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 0.86860970 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 0.85048124 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.83205255 |
| 70 | MP0000858_altered_metastatic_potential | 0.78471576 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.77139442 |
| 72 | MP0009115_abnormal_fat_cell | 0.72861346 |
| 73 | MP0009278_abnormal_bone_marrow | 0.72057968 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.68021017 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 0.67409529 |
| 76 | MP0002928_abnormal_bile_duct | 0.66515230 |
| 77 | MP0003690_abnormal_glial_cell | 0.66305771 |
| 78 | MP0008260_abnormal_autophagy | 0.65513935 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.64849941 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.64672183 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.64230541 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.64230541 |
| 83 | MP0009840_abnormal_foam_cell | 0.64148047 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.62402624 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.61726375 |
| 86 | MP0003252_abnormal_bile_duct | 0.61617302 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.61171382 |
| 88 | MP0001663_abnormal_digestive_system | 0.60698431 |
| 89 | MP0000490_abnormal_crypts_of | 0.60536507 |
| 90 | MP0000383_abnormal_hair_follicle | 0.60424660 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.59734842 |
| 92 | MP0000371_diluted_coat_color | 0.58555597 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.58311383 |
| 94 | MP0002163_abnormal_gland_morphology | 0.57049584 |
| 95 | MP0003828_pulmonary_edema | 0.55882401 |
| 96 | MP0005164_abnormal_response_to | 0.54605914 |
| 97 | MP0005166_decreased_susceptibility_to | 0.54140472 |
| 98 | MP0000249_abnormal_blood_vessel | 0.52847797 |
| 99 | MP0000343_altered_response_to | 0.52695265 |
| 100 | MP0008874_decreased_physiological_sensi | 0.52295254 |
| 101 | MP0005381_digestive/alimentary_phenotyp | 0.51822586 |
| 102 | MP0009763_increased_sensitivity_to | 0.51799817 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 0.51431854 |
| 104 | * MP0002693_abnormal_pancreas_physiology | 0.51116425 |
| 105 | MP0008004_abnormal_stomach_pH | 0.50657940 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.49616986 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.49368062 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.47516689 |
| 109 | MP0003795_abnormal_bone_structure | 0.47265545 |
| 110 | MP0001851_eye_inflammation | 0.46978998 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.46147157 |
| 112 | MP0010678_abnormal_skin_adnexa | 0.46012457 |
| 113 | MP0010307_abnormal_tumor_latency | 0.44491200 |
| 114 | MP0000604_amyloidosis | 0.43376334 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.41853767 |
| 116 | MP0002009_preneoplasia | 0.41840003 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.41152442 |
| 118 | MP0003011_delayed_dark_adaptation | 0.40993686 |
| 119 | MP0005390_skeleton_phenotype | 0.40233195 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.40218380 |
| 121 | MP0003075_altered_response_to | 0.39833451 |
| 122 | MP0000609_abnormal_liver_physiology | 0.39563857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Agammaglobulinemia (HP:0004432) | 6.52090977 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 6.39253108 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.35796086 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.27213324 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.23224579 |
| 6 | Recurrent bronchitis (HP:0002837) | 5.03940344 |
| 7 | Cellulitis (HP:0100658) | 5.00336874 |
| 8 | * Recurrent viral infections (HP:0004429) | 4.91710914 |
| 9 | Recurrent sinusitis (HP:0011108) | 4.84006579 |
| 10 | Chronic otitis media (HP:0000389) | 4.67291238 |
| 11 | Vasculitis (HP:0002633) | 4.60639126 |
| 12 | * Recurrent fungal infections (HP:0002841) | 4.49952404 |
| 13 | * Colitis (HP:0002583) | 4.29604195 |
| 14 | Emphysema (HP:0002097) | 4.19750038 |
| 15 | * Recurrent cutaneous fungal infections (HP:0011370) | 4.16139136 |
| 16 | * Chronic mucocutaneous candidiasis (HP:0002728) | 4.16139136 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.14823639 |
| 18 | Lymphopenia (HP:0001888) | 4.14210400 |
| 19 | IgM deficiency (HP:0002850) | 4.05992260 |
| 20 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.02864944 |
| 21 | * Recurrent skin infections (HP:0001581) | 3.95087374 |
| 22 | * Meningitis (HP:0001287) | 3.95034865 |
| 23 | Recurrent pneumonia (HP:0006532) | 3.84183691 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80020821 |
| 25 | Chronic sinusitis (HP:0011109) | 3.79662455 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75147027 |
| 27 | * Inflammation of the large intestine (HP:0002037) | 3.73593539 |
| 28 | Verrucae (HP:0200043) | 3.65006622 |
| 29 | Papilloma (HP:0012740) | 3.65006622 |
| 30 | Myositis (HP:0100614) | 3.47508288 |
| 31 | * Gastrointestinal inflammation (HP:0004386) | 3.46309913 |
| 32 | * Recurrent lower respiratory tract infections (HP:0002783) | 3.43586119 |
| 33 | Interstitial pulmonary disease (HP:0006530) | 3.41135166 |
| 34 | Osteomyelitis (HP:0002754) | 3.38695087 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.33134954 |
| 36 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31550814 |
| 37 | IgA deficiency (HP:0002720) | 3.29808207 |
| 38 | Increased IgE level (HP:0003212) | 3.20627388 |
| 39 | Restrictive lung disease (HP:0002091) | 3.19660560 |
| 40 | Gingivitis (HP:0000230) | 3.18008792 |
| 41 | Optic neuritis (HP:0100653) | 3.16670753 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 3.16670753 |
| 43 | Abnormality of macrophages (HP:0004311) | 3.02760312 |
| 44 | Periodontitis (HP:0000704) | 2.99518005 |
| 45 | Nasal polyposis (HP:0100582) | 2.99287554 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.98289499 |
| 47 | Obstructive lung disease (HP:0006536) | 2.98284412 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98284412 |
| 49 | Pustule (HP:0200039) | 2.93730641 |
| 50 | Leukopenia (HP:0001882) | 2.93439090 |
| 51 | Keratoconjunctivitis (HP:0001096) | 2.93292357 |
| 52 | Stomatitis (HP:0010280) | 2.92409221 |
| 53 | Thrombocytosis (HP:0001894) | 2.92172341 |
| 54 | Orchitis (HP:0100796) | 2.87078812 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.87036872 |
| 56 | Arterial thrombosis (HP:0004420) | 2.83864057 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.80841733 |
| 58 | Bronchitis (HP:0012387) | 2.74665136 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.67834047 |
| 60 | IgG deficiency (HP:0004315) | 2.67476805 |
| 61 | Myocardial infarction (HP:0001658) | 2.65285737 |
| 62 | Epistaxis (HP:0000421) | 2.65019304 |
| 63 | Chronic diarrhea (HP:0002028) | 2.60855622 |
| 64 | * Panhypogammaglobulinemia (HP:0003139) | 2.60804111 |
| 65 | Sepsis (HP:0100806) | 2.58798705 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.57460896 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.57283257 |
| 68 | Abnormality of the fingertips (HP:0001211) | 2.56529136 |
| 69 | Skin ulcer (HP:0200042) | 2.51288797 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.50175754 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47737176 |
| 72 | Arthralgia (HP:0002829) | 2.41806490 |
| 73 | Thyroiditis (HP:0100646) | 2.40712552 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.38880252 |
| 75 | Chest pain (HP:0100749) | 2.36312312 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.35203927 |
| 77 | Type 2 muscle fiber atrophy (HP:0003554) | 2.35191699 |
| 78 | Recurrent otitis media (HP:0000403) | 2.35148674 |
| 79 | Hematochezia (HP:0002573) | 2.32954080 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.30533259 |
| 81 | Mitral stenosis (HP:0001718) | 2.30158814 |
| 82 | Pulmonary embolism (HP:0002204) | 2.27535660 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.26863316 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26115505 |
| 85 | Xerostomia (HP:0000217) | 2.25926406 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.24389829 |
| 87 | Muscle fiber atrophy (HP:0100295) | 2.23629939 |
| 88 | * Encephalitis (HP:0002383) | 2.19975407 |
| 89 | Lymphoma (HP:0002665) | 2.16552355 |
| 90 | Gingival bleeding (HP:0000225) | 2.16347997 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.12411837 |
| 92 | Eosinophilia (HP:0001880) | 2.12104405 |
| 93 | Abnormality of eosinophils (HP:0001879) | 2.10112558 |
| 94 | Malnutrition (HP:0004395) | 2.07844802 |
| 95 | Urticaria (HP:0001025) | 2.07836971 |
| 96 | Leukocytosis (HP:0001974) | 2.07654826 |
| 97 | Increased IgM level (HP:0003496) | 2.07158464 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 2.06391432 |
| 99 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06391432 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 2.04913364 |
| 101 | Skin rash (HP:0000988) | 2.04718627 |
| 102 | Stomach cancer (HP:0012126) | 2.04483105 |
| 103 | B lymphocytopenia (HP:0010976) | 2.03724173 |
| 104 | Abnormality of B cell number (HP:0010975) | 2.03724173 |
| 105 | T lymphocytopenia (HP:0005403) | 2.03211847 |
| 106 | Basal ganglia calcification (HP:0002135) | 2.01330879 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 2.00582811 |
| 108 | Acrocyanosis (HP:0001063) | 1.99727847 |
| 109 | * Abnormality of T cells (HP:0002843) | 1.99471196 |
| 110 | Hemoptysis (HP:0002105) | 1.99234886 |
| 111 | Fatigue (HP:0012378) | 1.98983601 |
| 112 | Hypochromic anemia (HP:0001931) | 1.97353294 |
| 113 | Severe combined immunodeficiency (HP:0004430) | 1.95212165 |
| 114 | Gangrene (HP:0100758) | 1.90274791 |
| 115 | * Abnormality of T cell physiology (HP:0011840) | 1.90107618 |
| 116 | Cheilitis (HP:0100825) | 1.86198793 |
| 117 | Pulmonary fibrosis (HP:0002206) | 1.85441849 |
| 118 | Granulocytopenia (HP:0001913) | 1.84760317 |
| 119 | Premature loss of primary teeth (HP:0006323) | 1.84632522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.78629174 |
| 2 | MAP3K14 | 4.50215846 |
| 3 | BLK | 3.65984128 |
| 4 | RIPK4 | 3.26259177 |
| 5 | MAP3K13 | 3.12733058 |
| 6 | TYK2 | 3.12702400 |
| 7 | IRAK4 | 2.58125376 |
| 8 | CSF1R | 2.54856416 |
| 9 | TAOK3 | 2.51665383 |
| 10 | KIT | 2.51473507 |
| 11 | TBK1 | 2.45725846 |
| 12 | JAK3 | 2.34851697 |
| 13 | JAK1 | 2.34682446 |
| 14 | SYK | 2.33765475 |
| 15 | IRAK3 | 2.31999652 |
| 16 | PRPF4B | 2.28586154 |
| 17 | IKBKB | 2.26552462 |
| 18 | BTK | 2.13716774 |
| 19 | TNK2 | 2.04234417 |
| 20 | IKBKE | 2.00877485 |
| 21 | ERN1 | 1.91467246 |
| 22 | GRK6 | 1.88223895 |
| 23 | STK10 | 1.76788182 |
| 24 | CHUK | 1.73456108 |
| 25 | LRRK2 | 1.68068116 |
| 26 | FGFR4 | 1.63516807 |
| 27 | CSK | 1.54095278 |
| 28 | MAP3K10 | 1.40082042 |
| 29 | MST4 | 1.39230858 |
| 30 | LYN | 1.37271281 |
| 31 | SIK2 | 1.31851579 |
| 32 | EPHB1 | 1.28954755 |
| 33 | HCK | 1.26393431 |
| 34 | FGFR3 | 1.24461043 |
| 35 | TEC | 1.22235852 |
| 36 | EPHA3 | 1.21855969 |
| 37 | FRK | 1.15976085 |
| 38 | ZAP70 | 1.14581662 |
| 39 | TAOK2 | 1.09822085 |
| 40 | CLK1 | 1.09437972 |
| 41 | ITK | 1.07328217 |
| 42 | MATK | 1.02315546 |
| 43 | PRKCQ | 1.00317157 |
| 44 | ACVR1B | 1.00070726 |
| 45 | LCK | 0.96795378 |
| 46 | MAPK12 | 0.95120458 |
| 47 | NEK9 | 0.94418314 |
| 48 | GRK1 | 0.93085143 |
| 49 | MARK2 | 0.93055189 |
| 50 | SIK3 | 0.90212924 |
| 51 | TGFBR2 | 0.88649249 |
| 52 | MARK3 | 0.88403769 |
| 53 | JAK2 | 0.88267705 |
| 54 | PIK3CG | 0.85607026 |
| 55 | RPS6KA4 | 0.82815895 |
| 56 | FES | 0.81791631 |
| 57 | CDK12 | 0.80452729 |
| 58 | PIM1 | 0.79253817 |
| 59 | CDK4 | 0.77416092 |
| 60 | MAP2K3 | 0.72744956 |
| 61 | NLK | 0.69989079 |
| 62 | MAP3K1 | 0.69325482 |
| 63 | FGR | 0.67546144 |
| 64 | PDK1 | 0.65328528 |
| 65 | MELK | 0.61234157 |
| 66 | ALK | 0.60350701 |
| 67 | ABL1 | 0.59035351 |
| 68 | BMPR2 | 0.58658508 |
| 69 | * CDC42BPA | 0.56183323 |
| 70 | TRPM7 | 0.54999607 |
| 71 | SGK2 | 0.53087480 |
| 72 | MAP3K11 | 0.51941643 |
| 73 | PRKCD | 0.51814296 |
| 74 | PTK2B | 0.50421435 |
| 75 | PRKCH | 0.48361012 |
| 76 | CDK6 | 0.47305079 |
| 77 | MAP3K8 | 0.46686610 |
| 78 | STK4 | 0.45735435 |
| 79 | GRK7 | 0.43304211 |
| 80 | HIPK2 | 0.41701676 |
| 81 | CAMKK1 | 0.41434748 |
| 82 | SIK1 | 0.41418060 |
| 83 | DAPK2 | 0.41177795 |
| 84 | TTN | 0.41131262 |
| 85 | SCYL2 | 0.40867379 |
| 86 | CAMK1G | 0.40517301 |
| 87 | EGFR | 0.40433439 |
| 88 | YES1 | 0.40426109 |
| 89 | EEF2K | 0.40410121 |
| 90 | MAPKAPK2 | 0.40313196 |
| 91 | IRAK1 | 0.39064797 |
| 92 | MAPK4 | 0.37855038 |
| 93 | BRD4 | 0.37453838 |
| 94 | PKN1 | 0.36808555 |
| 95 | CAMK1D | 0.36723528 |
| 96 | PRKAA2 | 0.36676061 |
| 97 | PTK6 | 0.36476924 |
| 98 | STK11 | 0.36275384 |
| 99 | MAP2K2 | 0.35404849 |
| 100 | TXK | 0.35373118 |
| 101 | MAPK11 | 0.34061151 |
| 102 | RPS6KC1 | 0.33744089 |
| 103 | RPS6KL1 | 0.33744089 |
| 104 | NUAK1 | 0.33178294 |
| 105 | ADRBK2 | 0.33001548 |
| 106 | DYRK1B | 0.32584179 |
| 107 | PDPK1 | 0.32520538 |
| 108 | PKN2 | 0.31905517 |
| 109 | * MAPK3 | 0.30998710 |
| 110 | SMG1 | 0.30703150 |
| 111 | RET | 0.30702715 |
| 112 | INSR | 0.29918392 |
| 113 | FYN | 0.28234075 |
| 114 | TRIB3 | 0.24595680 |
| 115 | MAP3K3 | 0.23178629 |
| 116 | MAP3K7 | 0.22398145 |
| 117 | STK24 | 0.21752797 |
| 118 | PRKD2 | 0.21668245 |
| 119 | SGK3 | 0.21541979 |
| 120 | TAOK1 | 0.20767170 |
| 121 | TLK1 | 0.20341706 |
| 122 | EIF2AK2 | 0.17697856 |
| 123 | PRKD1 | 0.17273451 |
| 124 | RPS6KA5 | 0.15494852 |
| 125 | CDK9 | 0.15000083 |
| 126 | MAP3K5 | 0.14162081 |
| 127 | RPS6KA6 | 0.14092739 |
| 128 | MAPK7 | 0.13327072 |
| 129 | SRC | 0.12736683 |
| 130 | BMX | 0.12538984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.36424593 |
| 2 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 4.22898302 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.39067281 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.32616979 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90843634 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57242067 |
| 7 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.53474556 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36744206 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21437682 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.19257618 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.06891182 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.03872437 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99196335 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95349324 |
| 15 | * Tuberculosis_Homo sapiens_hsa05152 | 1.88134419 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87695575 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83553210 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81609084 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79475876 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78329117 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.77242614 |
| 22 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.68345296 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67525601 |
| 24 | * Influenza A_Homo sapiens_hsa05164 | 1.62575490 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.60919990 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54439634 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47992765 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46971732 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.45586373 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45086023 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.45061989 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43750747 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.35894991 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33646963 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.28357405 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24392894 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23899242 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23681137 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18943513 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16095706 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.15715908 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11455596 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05899654 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03298003 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.03009023 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.02660710 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98561619 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94852720 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94598601 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92425510 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90053157 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88626554 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82476445 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82472696 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80096747 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.79824668 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79678560 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.79030066 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78136045 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76165031 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75497984 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.75258014 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72411314 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71033389 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67740765 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61125780 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60027894 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58157165 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56687897 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54222372 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52568101 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50979312 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.50376966 |
| 74 | Base excision repair_Homo sapiens_hsa03410 | 0.49538783 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48002891 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47570943 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47300475 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47257079 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45773830 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44269357 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43438748 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42983574 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.42770961 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42585914 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42306718 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39729931 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37393909 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37046166 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34995577 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34804920 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34135841 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31952326 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31125576 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30804085 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30767930 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30552395 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30068337 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29553012 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.29083410 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28849013 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27429972 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26279827 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.23947340 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.23847746 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23434714 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22292883 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20366636 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19674162 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.19458814 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.19266561 |
| 111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19092293 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18861700 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.17438853 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17415315 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16416982 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16139404 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.16035518 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14113737 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13474272 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12156293 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.10124675 |

